CSK Biotech — Scalable CDMO for Bespoke Nutritional Supplements

CSK Biotech offers end-to-end CDMO services covering concept development, formulation research, pilot testing, stability verification, and full-scale production. We manufacture capsules (softgels and hardcaps), tablets, powders, gummies, and liquids, and provide professional R&D, bespoke formulation development, stability testing, and free packaging services. With a GMP-certified 2,000㎡ facility, seven advanced production lines and annual capacity exceeding 4.5 billion softgels and 1.5 billion tablets, CSK Biotech delivers scalable manufacturing solutions for global brands, including customers searching for dietary supplement contract manufacturers in usa.

Quality and compliance are central to our CDMO model. CSK Biotech operates under international standards—GMPC, HACCP, ISO—and is registered with the FDA. We maintain strict GMP processes, in-process controls, validated analytical methods, and comprehensive batch documentation. Stability studies, traceability of raw materials, and third-party testing capabilities are available to support regulatory filings and market entry for U.S. and global markets. Our QA team supports regulatory strategy and documentation to help clients meet country-specific requirements.

CSK Biotech offers three flexible cooperation models: ODM for market-driven, ready-to-launch product concepts (we provide formulation, branding-ready options, and marketing support); CDM for customized formula design tailored to your target claims and specifications (collaborative R&D and pilot runs); and OEM for exact formula-based manufacturing where you supply the formula and we ensure precise, timely production. Choose ODM if you want fast-to-market, research-backed products; CDM if you need a bespoke formulation with technical support; and OEM if you have an established formula and require reliable scale-up and production.

Lead times vary by project complexity: formulation development and stability verification for a new product typically take 8–16 weeks; pilot-to-production scale-up can add additional time. Repeat OEM production runs typically require shorter lead times (often 4–8 weeks depending on scheduling and product). MOQs depend on dosage form, ingredients, and packaging—CSK supports pilot batches for R&D and sample purposes and can scale to mass production thanks to our high annual capacities. Exact MOQs and timelines are provided after reviewing the formulation, packaging, and regulatory needs.

To start, contact our business team with your concept, target dosage form, estimated volumes, and any regulatory constraints—email steve@cskbiotech.com or visit https://www.cskbiotech.com/ to submit inquiries. We provide a structured onboarding process: initial feasibility and costing, NDA and project proposal, formulation/pilot testing, stability and regulatory support, and full production and packaging. For U.S. market entry we assist with labeling guidance, documentation for FDA compliance, export paperwork, and any necessary analytical data to support regulatory submissions, helping brands confidently work with dietary supplement contract manufacturers in usa and internationally.